Literature DB >> 2973971

Pseudotumor cerebri caused by isotretinoin.

M Roytman1, A Frumkin, T G Bohn.   

Abstract

A 16-year-old girl treated with isotretinoin at a dosage of 0.7 mg per kg each day experienced severe headaches and impaired night vision two months after the start of therapy. Bilateral papilledema and narrowing of the lateral ventricles of the brain were found. Pseudotumor cerebri and impaired night vision abated when isotretinoin was discontinued and systemic corticosteroids (dexamethasone) were administered.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973971

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  6 in total

Review 1.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Retinoic acid and affective disorders: the evidence for an association.

Authors:  J Douglas Bremner; Kirsty D Shearer; Peter J McCaffery
Journal:  J Clin Psychiatry       Date:  2011-08-23       Impact factor: 4.384

Review 3.  Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.

Authors:  Elisabeth Chroni; Alexandra Monastirli; Dionysios Tsambaos
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 4.  Epidemiology and risk factors for idiopathic intracranial hypertension.

Authors:  John Chen; Michael Wall
Journal:  Int Ophthalmol Clin       Date:  2014

Review 5.  Ocular complications associated with systemic medications used in allergy/immunology practice.

Authors:  Avinash Gurbaxani; Clare L Fraser; Simon E Skalicky; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

6.  Reversible bilateral optic disc swelling in a renal patient treated with nitrofurantoin.

Authors:  Edward Pringle; Henrietta Ho; Eoin O'Sullivan; Charles Soper
Journal:  NDT Plus       Date:  2008-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.